Two Stocks in Concentration: Intellipharmaceutics International Inc. (NASDAQ:IPCI), Danaos Corporation (NYSE:DAC)


Intellipharmaceutics International Inc. (NASDAQ:IPCI)

Intellipharmaceutics International Inc. (NASDAQ:IPCI) represented a move of 0 percent or $0.01 per share and closed its previous day trading session at $0.3. 0 Shares were traded in the last trading session with an Average Volume of 1.01 Million Shares. The stock currently has a Market Capitalization of 2.91 Million.

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.

The stock traded between $ 0.290 and $10.500 over 1-Year time period showing its price to sales ratio of 1.21. Intellipharmaceutics International Inc. (NASDAQ:IPCI) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-67.69 and 200-Day Simple Moving Average of $-91.49. Its Price to Free Cash Flow is 0 and Price to Book of 0.

Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Intellipharmaceutics International Inc. (NASDAQ:IPCI) reported its Actual EPS of $-0.7/share. The analysts offering Earnings Estimates for the company were believing that Intellipharmaceutics International Inc. could bring EPS of $-0.7/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.

Danaos Corporation (NYSE:DAC)

In the last trading session, Danaos Corporation (NYSE:DAC) added its value by 0% closing at the price of $1.04. The stock currently has market capitalization of 230.28 Million, with average volume of 86.7 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Danaos Corporation (NYSE:DAC) is showing beta of 0.83. This particular value of beta suggests that Danaos Corporation (NYSE:DAC) has historically moved 83% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Danaos Corporation (NYSE:DAC) is at $1.17.

The stock currently has RSI of 44.28. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Danaos Corporation is a leading international owner of containerships, chartering vessels to many of the world’s largest liner companies. Danaos was set up by Dimitri Coustas, an experienced shipping investor who had been active in the industry. Having consistently developed sea transport services throughout its history, Danaos has forged a reputation for high-quality operational support to liner companies and other charterers throughout the world. The Company currently have a fleet of containerships aggregating TEU, making us among the largest containership charter owners in the world. We charter our containerships to a geographically diverse group of liner companies, including most of the largest ones globally. Such customers include Maersk, COSCO, Hapag-Lloyd, CMA-CGM, Neptune Orient Lines, Yang Ming, China Shipping, Norasia Container Lines Ltd, Hyundai Merchant Marine Co., Wan-Hai Lines and Zim Israel Integrated Shipping Services Ltd.

Danaos Corporation (NYSE:DAC) topped its 52-week high price of $2.50 on 07/09/18 and 52-Week Low Price of $1.01 on 11/12/18. The Stock currently has P/E (price to earnings ttm) of 0.89 and Weekly volatility of 6.05% and monthly volatility of 6.35% respectively.